Definitive Contract 36C25723C0042

Award Date 3/18/23
Potential Completion Date 3/17/28
Potential Value $3.2M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Antonio, TX 78229, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 (VA - VHA) awarded a $3.5 million Firm Fixed Price definitive contract to Austin Nuclear Pharmacy Services LLC to provide radiopharmaceuticals. The place of performance will be in Temple, Texas and the contract period runs from August 9, 2023 through August 8, 2028. No subcontractors were identified. Radiopharmaceuticals are radioactive pharmaceuticals used in medical imaging and treatment...
This is a federal contract award to Panhandle Nuclear RX, LTD., a for-profit partnership or limited liability partnership based in Amarillo, Texas. The contract, valued at $202,815.00, is for the provision of radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 17 (VISN 17). The contract is a Delivery Order under a single-award Indefinite Delivery Contract (IDV) with the VA, valued at $615,206 and running through January 3,...
This is a $963,779.11 firm fixed-price contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Panhandle Nuclear RX, LTD., a for-profit small business based in Amarillo, Texas. The contract is for the provision of radiopharmaceuticals to support diagnostic imaging services within the VA's Veterans Integrated Service Network 17 (VISN 17). The contract has a period of performance from January 4, 2021 through January 3, 2023 and was awarded under a...
This contract award is for the provision of radiopharmaceuticals to the U.S. Department of Veterans Affairs' Veterans Integrated Service Network 17 (VISN 17) in Amarillo, Texas. The award, valued at $307,603.00, was made to Panhandle Nuclear RX, LTD., a for-profit partnership or limited liability partnership based in Amarillo. The contract is a Firm Fixed Price Purchase Order and has a completion date of April 30, 2026. This award is part of a larger Indefinite Delivery Contract (IDV) between...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm fixed price delivery order contract to Panhandle Nuclear RX, LTD., a for-profit limited liability partnership based in Amarillo, Texas. The $254,994.00 contract is for the provision of radiopharmaceuticals to support diagnostic imaging services for the VA's Veterans Integrated Service Network 17 (VISN 17) healthcare system. This is the latest in a series of contracts between Panhandle Nuclear RX, LTD. and...
This is a firm fixed price purchase order contract awarded by the Veterans Integrated Service Network 17 (VISN 17) of the U.S. Department of Veterans Affairs (VA) to Panhandle Nuclear RX, LTD., a for-profit partnership or limited liability partnership based in Amarillo, Texas. The contract is for the provision of radiopharmaceuticals, with a ceiling value of $38,009.00 and a period of performance through April 30, 2025. This contract is not set aside and is part of a larger Indefinite Delivery...
This federal contract award is for the provision of radioactive pharmaceuticals to the Department of Veterans Affairs (VA) Veterans Integrated Service Network 17 (VISN 17). The prime contractor, Panhandle Nuclear RX, LTD., was awarded a Blanket Purchase Agreement (BPA) call contract valued at $387,035.00 with a performance period from October 1, 2016 to September 30, 2018. The contract is for firm fixed-price radiopharmaceutical products to support diagnostic imaging services for veterans....
This federal contract award to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., is for the supply of nuclear medicine radiopharmaceuticals to the South Texas VA Health Care System. The $865,901.61 firm-fixed-price purchase order supports the VA's diagnostic imaging and cancer treatment programs, providing a range of radioisotopes with very short half-lives, such as technetium-99m, iodine-123, and fluorine-18 FDG. The contract originated from a solicitation issued by the...
This is a delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 17 to Panhandle Nuclear RX, LTD., a small business based in Amarillo, Texas. The contract is for the provision of radiopharmaceutical products to support diagnostic imaging services for the VA healthcare system within VISN 17. The contract has a ceiling value of $145,743.00 and is a firm fixed-price delivery order contract with a period of performance from October 1,...
<p>The Department of Veterans Affairs Veterans Health Administration awarded a $565,292.47 firm-fixed-price delivery order contract to A Pharmacy Corporation Pharmatron, a minority-owned, self-certified small disadvantaged business, for the provision of radiopharmaceuticals. The contract has a completion date of September 30, 2018 and was awarded on October 1, 2017. The place of performance is Fresno, California. This contract was not set aside for any specific business type.</p>

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded a five-year, $3.2 million firm fixed price contract to Alamo Nuclear Pharmacy Services Inc. to provide radiopharmaceuticals in support of nuclear medicine services at the South Texas VA Healthcare System in San Antonio, Texas. The solicitation requested quotes for an indefinite delivery, indefinite quantity contract to timely deliver both low-energy diagnostic radiotracers and high-energy positron emission tomography radiopharmaceuticals. There was no set-aside designated for this requirement. Pricing was required to be submitted using an attached spreadsheet detailing unit costs for 68 radiopharmaceutical products and services over the potential five-year ordering period through March 2028. Evaluation was based on a nuclear pharmacy's ability to timely deliver the products to the specified VA location.

Generated 12/29/23, 5:01 PM